BioCentury
ARTICLE | Company News

Schwarz submits Neupro NDA, MAA

September 29, 2004 7:00 AM UTC

Schwarz (Monheim, Germany) submitted an NDA to the FDA and an MAA to the EMEA for its Neupro transdermal rotigotine patch to treat Parkinson's disease (PD). The dopamine D2 receptor agonist continuous...